Risk factors of levodopa-induced dyskinesia in Parkinson’s disease: results from the PPMI cohort

Baseline demographics, PD characteristics, DaTscan levels, and CSF analytes (β-amyloid 1-42 [Ab42], total tau protein [t-Tau], phosphorylated tau protein [p-Tau], and a-synuclein [α-syn